Operating Expenses Summary of OBI Pharma, Inc.

OBI Pharma, Inc.'s latest annual operating expenses in 2023 was 2.01 Billion TWD , down -3.18% from previous year.
OBI Pharma, Inc.'s latest quarterly operating expenses in 2024 Q3 was 518.97 Million TWD , down -103.16% from previous quarter.
OBI Pharma, Inc. reported a annual operating expenses of 2.08 Billion TWD in annual operating expenses 2022, up 23.2% from previous year.
OBI Pharma, Inc. reported a annual operating expenses of 1.69 Billion TWD in annual operating expenses 2021, up 5.63% from previous year.
OBI Pharma, Inc. reported a quarterly operating expenses of 491.09 Million TWD for 2024 Q1, up 3.93% from previous quarter.
OBI Pharma, Inc. reported a quarterly operating expenses of 518.97 Million TWD for 2024 Q3, down -103.16% from previous quarter.

Annual Operating Expenses Chart of OBI Pharma, Inc. (2023 - 2011)

Historical Annual Operating Expenses of OBI Pharma, Inc. (2023 - 2011)

Year	Operating Expenses	Operating Expenses Growth
2023	2.01 Billion TWD	-3.18%
2022	2.08 Billion TWD	23.2%
2021	1.69 Billion TWD	5.63%
2020	1.6 Billion TWD	10.23%
2019	1.45 Billion TWD	1.11%
2018	1.43 Billion TWD	20.65%
2017	1.19 Billion TWD	-1.23%
2016	1.2 Billion TWD	13.33%
2015	1.06 Billion TWD	49.26%
2014	712.32 Million TWD	52.32%
2013	467.65 Million TWD	64.61%
2012	284.1 Million TWD	100.58%
2011	141.63 Million TWD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	477.24 Million TWD	-2.82%
2024 Q1	491.09 Million TWD	3.93%
2024 Q3	518.97 Million TWD	-103.16%
2023 Q3	596.53 Million TWD	11.65%
2023 Q4	472.53 Million TWD	-20.79%
2023 FY	2.01 Billion TWD	-3.18%
2023 Q1	412.95 Million TWD	-34.53%
2023 Q2	534.27 Million TWD	29.38%
2022 FY	2.08 Billion TWD	23.2%
2022 Q3	592.23 Million TWD	27.45%
2022 Q1	394.96 Million TWD	-33.38%
2022 Q2	464.66 Million TWD	17.65%
2022 Q4	630.74 Million TWD	6.5%
2021 Q4	592.82 Million TWD	50.8%
2021 FY	1.69 Billion TWD	5.63%
2021 Q2	428.67 Million TWD	55.42%
2021 Q3	393.1 Million TWD	-8.3%
2021 Q1	275.82 Million TWD	-47.4%
2020 Q1	369.77 Million TWD	-15.91%
2020 Q3	366.1 Million TWD	7.67%
2020 Q2	340.03 Million TWD	-8.04%
2020 FY	1.6 Billion TWD	10.23%
2020 Q4	524.38 Million TWD	43.23%
2019 Q2	413.96 Million TWD	58.85%
2019 FY	1.45 Billion TWD	1.11%
2019 Q1	260.59 Million TWD	-41.58%
2019 Q3	337.44 Million TWD	-18.48%
2019 Q4	439.72 Million TWD	30.31%
2018 Q3	440.4 Million TWD	37.11%
2018 Q1	228.06 Million TWD	-29.04%
2018 FY	1.43 Billion TWD	20.65%
2018 Q4	446.05 Million TWD	1.28%
2018 Q2	321.2 Million TWD	40.84%
2017 FY	1.19 Billion TWD	-1.23%
2017 Q4	321.41 Million TWD	-7.16%
2017 Q3	346.21 Million TWD	9.83%
2017 Q2	315.23 Million TWD	52.17%
2017 Q1	207.15 Million TWD	-43.31%
2016 FY	1.2 Billion TWD	13.33%
2016 Q1	281.52 Million TWD	2.85%
2016 Q4	365.41 Million TWD	17.46%
2016 Q2	246.85 Million TWD	-12.31%
2016 Q3	311.09 Million TWD	26.02%
2015 Q2	184.03 Million TWD	-50.94%
2015 FY	1.06 Billion TWD	49.26%
2015 Q4	273.72 Million TWD	18.83%
2015 Q3	230.34 Million TWD	25.16%
2015 Q1	375.1 Million TWD	88.18%
2014 Q3	160.28 Million TWD	-29.75%
2014 Q2	228.15 Million TWD	83.19%
2014 Q1	124.54 Million TWD	-12.64%
2014 FY	712.32 Million TWD	52.32%
2014 Q4	199.33 Million TWD	24.37%
2013 Q1	102.31 Million TWD	31.07%
2013 Q2	155.39 Million TWD	51.88%
2013 FY	467.65 Million TWD	64.61%
2013 Q3	103.92 Million TWD	-33.12%
2013 Q4	142.56 Million TWD	37.17%
2012 Q4	78.06 Million TWD	0.0%
2012 Q3	78.06 Million TWD	0.0%
2012 FY	284.1 Million TWD	100.58%
2011 FY	141.63 Million TWD	0.0%

Peer Operating Expenses Comparison of OBI Pharma, Inc.

Name	Operating Expenses	Operating Expenses Difference
SYN-TECH Chem. & Pharm. Co., Ltd.	127.67 Million TWD	-1479.301%
Level Biotechnology Inc.	151.99 Million TWD	-1226.57%
Sagittarius Life Science Corp	135.85 Million TWD	-1384.173%
NeoCore Technology Co., Ltd.	75.85 Million TWD	-2557.95%
TaiMed Biologics Inc.	225.23 Million TWD	-795.204%
GlycoNex Incorporation	995 Thousand TWD	-202542.613%
VBI	32.55 Million TWD	-6093.5%
GeneReach Biotechnology Corp.	256.86 Million TWD	-684.95%
Taiwan Advance Bio-Pharmaceutical Inc.	194.18 Million TWD	-938.331%
Visgeneer Inc.	67.48 Million TWD	-2887.899%
Mycenax Biotech Inc.	-375.19 Million TWD	637.405%
Sunmax Biotechnology Co., Ltd.	510.09 Million TWD	-295.278%
G&E Herbal Biotechnology Co., Ltd.	63.9 Million TWD	-3055.242%
Medigen Vaccine Biologics Corporation	1.44 Billion TWD	-39.628%
TaiwanJ Pharmaceuticals Co., Ltd.	29.35 Million TWD	-6769.358%
Enimmune corporation	220.1 Million TWD	-816.073%
TaiRx, Inc.	217.13 Million TWD	-828.594%
CHO Pharma, Inc.	268.99 Million TWD	-649.557%
EirGenix Inc.	236.74 Million TWD	-751.688%
BioLASCO Taiwan Co., Ltd.	104.35 Million TWD	-1832.223%
Sunny Pharmtech Inc.	357.62 Million TWD	-463.806%
Lin BioScience, Inc.	1.09 Billion TWD	-83.83%
BioGend Therapeutics Co., Ltd.	266.15 Million TWD	-657.552%
Feng Chi Biotech Corp.	49.47 Million TWD	-3975.709%
Bio Preventive Medicine Corp.	1.08 Million TWD	-186076.731%
Lukas Biomedical Inc.	177.45 Million TWD	-1036.26%
RBC Bioscience Corporation	58.35 Million TWD	-3355.161%
BiOptic Inc.	108.69 Million TWD	-1755.053%
BRIM Biotechnology, Inc.	90 Thousand TWD	-2240226.667%
Shine-On BioMedical Co.,Ltd.	69.35 Million TWD	-2807.417%
Great Novel Therapeutics Biotech & Medicals	2.61 Million TWD	-77004.933%
Syngen Biotech Co.,Ltd.	643.91 Million TWD	-213.129%
Anti-Microbial Savior BioteQ Co., Ltd	329 Thousand TWD	-612755.319%
SynCore Biotechnology Co.,Ltd	46.02 Million TWD	-4281.057%
Genomics BioSci & Tech. Co.,Ltd.	119.91 Million TWD	-1581.506%
Neith Corporation	66.87 Million TWD	-2915.109%
Advagene Biopharma Co., Ltd.	93.33 Million TWD	-2060.253%
NaviFUS Corp.	11.82 Million TWD	-16948.229%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	190.72 Million TWD	-957.151%
Sinew Pharma Inc.	186.25 Million TWD	-982.557%
Andros Pharmaceuticals Co.,Ltd	74.02 Million TWD	-2623.875%
Greenyn Biotechnology Co., Ltd	220.39 Million TWD	-814.842%
Lumosa Therapeutics Co., Ltd.	41.48 Million TWD	-4760.765%
AP Biosciences Inc	32.25 Million TWD	-6151.493%
Medigen Biotechnology Corp.	1.85 Billion TWD	-8.964%
3D Global Biotech Inc.	5.27 Million TWD	-38130.83%
Pharmosa Biopharm Inc.	317.32 Million TWD	-535.405%
Intech Biopharm Corporation	-163.99 Million TWD	1329.485%
Oneness Biotech Co., Ltd.	1.12 Billion TWD	-78.562%
Eusol Biotech Co.,Ltd.	41.48 Million TWD	-4760.648%
TWi Biotechnology, Inc.	169.55 Million TWD	-1089.161%
Ever Supreme Bio Technology Co., Ltd	147.02 Million TWD	-1271.423%
TCI GENE Inc.	174.61 Million TWD	-1054.695%
MegaPro Biomedical Co., Ltd	18 Thousand TWD	-11201533.333%
Senhwa Biosciences, Inc.	300.93 Million TWD	-570.003%
Taiwan Bio Therapeutics Co., Ltd	290.95 Million TWD	-592.987%
NatureWise Biotech & Medicals Corporation	83.94 Million TWD	-2301.923%
PharmaEngine, Inc.	441.78 Million TWD	-356.393%
Savior Lifetec Corporation	223.36 Million TWD	-802.674%
TaiGen Biopharmaceuticals Holdings Limited	258.77 Million TWD	-679.157%
Meribank Biotech Co., Ltd	138.87 Million TWD	-1351.929%
Acepodia, Inc.	452.56 Million TWD	-345.524%
Caliway Biopharmaceuticals Co., Ltd.	540.93 Million TWD	-272.741%

Global Stocks Search

OBI Pharma, Inc. (4174.TWO)

Operating Expenses Summary of OBI Pharma, Inc.

Annual Operating Expenses Chart of OBI Pharma, Inc. (2023 - 2011)

Historical Annual Operating Expenses of OBI Pharma, Inc. (2023 - 2011)

Peer Operating Expenses Comparison of OBI Pharma, Inc.